Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Gamida Cell (GMDAQ)
OTHER OTC:GMDAQ
Holding GMDAQ?
Track your performance easily
GMDAQ Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range<$0.01 - $2.51
Previous Close$0.02
Volume332.75K
Average Volume (3M)8.97M
Market Cap
$2.56M
Enterprise Value$28.05M
Total Cash (Recent Filing)$60.43M
Total Debt (Recent Filing)$85.93M
Price to Earnings (P/E)―
Beta1.14
Next Earnings
Aug 12, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.51
Shares Outstanding154,013,109
10 Day Avg. Volume348,701
30 Day Avg. Volume8,968,305
Standard Deviation0.29
R-Squared0.04
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.10
Enterprise Value/Gross Profit-21.85
Enterprise Value/Ebitda-0.22
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Ownership Overview
6.14% Insiders
4.56% Mutual Funds
6.02% Other Institutional Investors
83.27% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
GMDAQ FAQ
What was Gamida Cell’s price range in the past 12 months?
Gamida Cell lowest stock price was <$0.01 and its highest was $2.51 in the past 12 months.
What is Gamida Cell’s market cap?
Currently, no data Available
When is Gamida Cell’s upcoming earnings report date?
Gamida Cell’s upcoming earnings report date is Aug 12, 2024 which is 90 days ago.
How were Gamida Cell’s earnings last quarter?
Gamida Cell released its earnings results on May 07, 2024. The company reported -$0.131 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.131.
Is Gamida Cell overvalued?
According to Wall Street analysts Gamida Cell’s price is currently Overvalued.
Does Gamida Cell pay dividends?
Gamida Cell does not currently pay dividends.
What is Gamida Cell’s EPS estimate?
Gamida Cell’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Gamida Cell have?
Gamida Cell has 154,051,000 shares outstanding.
What happened to Gamida Cell’s price movement after its last earnings report?
Gamida Cell reported an EPS of -$0.131 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 100%.
Which hedge fund is a major shareholder of Gamida Cell?
Among the largest hedge funds holding Gamida Cell’s share is ARK Investment Management LLC. It holds Gamida Cell’s shares valued at 53.
---
Gamida Cell Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 2.1M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 11.6%
Last 30 Days ▼ 11.6%
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-24.33%
Trailing 12-Months
Company Description
Gamida Cell
Gamida Cell Ltd. is a clinical stage biopharmaceutical company engaging in the development of cell therapies to cure blood cancer and rare serious hematologic diseases. The company was founded by Tony Peled and Menashe Levy in 1998 and is headquartered in Jerusalem, Israel.
---
GMDAQ Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Adverum Biotechnologies
―
Crispr Therapeutics AG
―
Meiragtx Holdings
―
Krystal Biotech
―
Best Analysts Covering GMDAQ
1 Year
1 Year Success Rate
2/20 ratings generated profit
1 Year Average Return
-38.51%
reiterated a buy rating 12 months ago
Copying Vernon Bernardino's trades and holding each position for 1 Year would result in 10.00% of your transactions generating a profit, with an average return of -38.51% per trade.
---